Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Oral Oncol. 2013 May;49(5):401-6. doi: 10.1016/j.oraloncology.2012.12.009. Epub 2013 Jan 16.

Stereotactic Body Radiotherapy (SBRT) for primary and recurrent head and neck tumors.

Author information

  • 1Department of Otolaryngology, University of Pittsburgh Medical Center, PA, USA.

Abstract

Stereotactic Body Radiotherapy (SBRT) is increasingly used to treat a variety of head and neck tumors as a result of its highly conformal dose distributions and stereotactic spatial accuracy in delivery. Our experience and other previous reports have shown that SBRT is technically feasible, well-tolerated and compares favorably to other alternatives of salvage therapy in the management of patients with recurrent and/or previously irradiated head and neck cancers. Furthermore, it has the advantage of a shorter treatment schedule, greater compliance, and safe delivery in the outpatient setting. This affords an opportunity to introduce SBRT as a definitive treatment in select patients. This review presents an overview of the use of SBRT for managing head and neck tumors by highlighting the existing indications and the expanding role of SBRT in managing these patients.

Copyright © 2012 Elsevier Ltd. All rights reserved.

PMID:
23332685
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk